KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Repligen (RGEN) Acquisitions (2011 - 2025)

Repligen (RGEN) reported Acquisitions of $374000.0 for Q4 2025, down 99.32% year-over-year from $54.8 million in Q4 2024, and up 59.83% on a QoQ basis from $234000.0 in Q2 2025.

Repligen (RGEN) has 10 years of Acquisitions data on file, last reported at $374000.0 in Q4 2025.

  • Quarterly Acquisitions fell 99.32% year-over-year to $374000.0 in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $608000.0 (down 99.51% YoY) and the FY2025 annual result came in at $70.3 million, up 28.42% from the prior year.
  • Acquisitions advanced to $374000.0 in Q4 2025 per RGEN's latest filing, from $234000.0 in the prior quarter.
  • Across five years, Acquisitions topped out at $158.8 million in Q4 2023 and bottomed at -$256000.0 in Q3 2023.
  • The 4-year median for Acquisitions is $28.9 million (2021), against an average of $48.2 million.
  • The widest annual swing landed in 2024, when Acquisitions sank 65.51%; it then sank 99.32% in 2025.
  • Tracing RGEN's Acquisitions over 4 years: stood at $28.9 million in 2021, then jumped by 449.21% to $158.8 million in 2023, then slumped by 65.51% to $54.8 million in 2024, then slumped by 99.32% to $374000.0 in 2025.
  • Per Business Quant, the three latest RGEN Acquisitions figures stand at $374000.0 (Q4 2025), $234000.0 (Q2 2025), and $69.7 million (Q1 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn 528.20 Mn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn -
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 24.88 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn -
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn -
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn -
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 18.96 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn -
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn -
10 Repligen 6.39 Bn 5.41 Bn 108.28 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 374,000.00
Jun 30, 2025 234,000.00
Mar 31, 2025 69.72 Mn
Dec 31, 2024 54.77 Mn
Dec 31, 2023 158.80 Mn
Sep 30, 2023 -256,000.00
Dec 31, 2021 28.91 Mn
Sep 30, 2021 121.05 Mn
Mar 31, 2021 -71,000.00
Dec 31, 2020 146.60 Mn
Sep 30, 2019 -22,000.00
Dec 31, 2017 -146,000.00
Dec 31, 2016 27.08 Mn
Sep 30, 2014 63.00
Dec 31, 2011 26.58 Mn